• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究铜绿假单胞菌感染及冷等离子体处理后兔角膜的组织形态计量学变化。

Investigating the histomorphometric changes of rabbit cornea after infection with Pseudomonas Aeruginosa and treatment with cold plasma.

作者信息

Goudarzi Amirsaeed, Sadraie Seyed Homayoun, Kaka Gholamreza, Aghamolaei Hossein, Jalali Bahman

机构信息

Department of Anatomical Sciences, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Neurology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

出版信息

Int Immunopharmacol. 2025 Aug 28;161:115028. doi: 10.1016/j.intimp.2025.115028. Epub 2025 Jun 9.

DOI:10.1016/j.intimp.2025.115028
PMID:40494206
Abstract

INTRODUCTION

Pseudomonas aeruginosa-caused ocular infections are dangerous since they can cause corneal inflammation, damage, and blindness. This work aims to carefully assess the histomorphometric and clinical changes in rabbit corneas caused by Pseudomonas aeruginosa infection, focusing on investigating the potential therapeutic benefits of cold plasma.

MATERIALS AND METHODS

The right eye served as an untreated control, and the animals were randomly divided into four groups: Hariprasad et al. (2008) [1] Control group (the left eye infected with P. aeruginosa); Statham et al. (2008) [2] Antibiotic-treated group; Chaudhry (2013) [3] Non-infected plasma group; and (Speaker et al., 1991 [4]) Infected plasma-treated group. Exams of the left eye were performed on twenty rabbits, divided into four groups: non-infected plasma treatment, plasma-treated infection, plasma-treated infection, and antibiotic-treated infection. Clinical factors were quantified by an ophthalmologist using pre-established scoring systems. Evaluations were conducted on keratocyte expression levels, keratocyte cell count, and histomorphometric indices. Additionally, ELISA tests were used to measure the levels interleukin-6, and C-reactive protein and colony count assays were used to quantify bacteria. HMOX-1 and NRF-2 gene expressions were examined using a real-time PCR technique.

RESULTS

A higher frequency of clinical markers, such as tear production, destruction of the eyelid margin, abnormalities, swelling, viscous secretions, corneal swelling, stromal edema, shortened distance between the eyelid margins, corneal hyperemia, intraocular bleeding, and conjunctival inflammation, was noted in the control group. All evaluated clinical indicators were dramatically reduced by both the plasma and antibiotic treatments. Histomorphometric analysis showed significant differences in keratinocyte levels, corneal endothelium, and epithelial thickness between the treatment groups and the control group. The control group's lymphocyte count and stromal layers were notably different from those of the other groups. Plasma treatment significantly raised keratinocytes and the thickness of the cornea's endothelial and epithelial layers while simultaneously lowering the number of lymphocytes and stromal layers. When compared to the infected control, the NRF-2 gene expression in the groups treated with plasma and antibiotics showed a notable decrease, with the plasma-treated group showing the most significant decline. Similarly, both the plasma- and antibiotic-treated groups' HMOX-1 gene expression showed a significant decline, with the plasma-treated group showing the largest decline. The group receiving plasma therapy had a considerable increase in keratinocyte expression. Furthermore, bacterial count, C-reactive protein, and interleukin-6 concentrations markedly decreased in the plasma treatment group compared to the control group.

CONCLUSION

This study highlights how well cold plasma therapy works to reduce the negative consequences of corneal infection. The results validate the anti-inflammatory characteristics of plasma and its capacity to inhibit bacterial growth.

摘要

引言

铜绿假单胞菌引起的眼部感染很危险,因为它们会导致角膜炎症、损伤和失明。这项工作旨在仔细评估铜绿假单胞菌感染引起的兔角膜组织形态计量学和临床变化,重点研究冷等离子体的潜在治疗益处。

材料与方法

右眼作为未治疗的对照,动物被随机分为四组:哈里普拉萨德等人(2008年)[1]对照组(左眼感染铜绿假单胞菌);斯塔瑟姆等人(2008年)[2]抗生素治疗组;乔杜里(2013年)[3]未感染血浆组;以及(斯皮克等人,1991年[4])感染血浆治疗组。对20只兔子的左眼进行检查,分为四组:未感染血浆治疗组、血浆治疗感染组、血浆治疗感染组和抗生素治疗感染组。眼科医生使用预先建立的评分系统对临床因素进行量化。对角膜细胞表达水平、角膜细胞计数和组织形态计量学指标进行评估。此外,酶联免疫吸附测定(ELISA)试验用于测量白细胞介素-6水平,C反应蛋白和菌落计数试验用于量化细菌。使用实时聚合酶链反应(PCR)技术检测血红素加氧酶-1(HMOX-1)和核因子E2相关因子2(NRF-2)基因表达。

结果

对照组中观察到更高频率的临床指标,如泪液分泌、睑缘破坏、异常、肿胀、粘性分泌物、角膜肿胀、基质水肿、睑缘间距离缩短、角膜充血、眼内出血和结膜炎症。血浆和抗生素治疗均显著降低了所有评估临床指标。组织形态计量学分析显示治疗组与对照组在角质形成细胞水平、角膜内皮和上皮厚度方面存在显著差异。对照组的淋巴细胞计数和基质层与其他组明显不同。血浆治疗显著增加了角质形成细胞以及角膜内皮和上皮层的厚度,同时降低了淋巴细胞数量和基质层。与感染对照组相比,血浆和抗生素治疗组中的NRF-2基因表达显著下降,血浆治疗组下降最为显著。同样,血浆和抗生素治疗组的HMOX-1基因表达均显著下降,血浆治疗组下降幅度最大。接受血浆治疗的组角质形成细胞表达有相当大的增加。此外,与对照组相比,血浆治疗组的细菌计数、C反应蛋白和白细胞介素-6浓度显著降低。

结论

本研究突出了冷等离子体疗法在减轻角膜感染负面影响方面的良好效果。结果证实了血浆的抗炎特性及其抑制细菌生长的能力。

相似文献

1
Investigating the histomorphometric changes of rabbit cornea after infection with Pseudomonas Aeruginosa and treatment with cold plasma.研究铜绿假单胞菌感染及冷等离子体处理后兔角膜的组织形态计量学变化。
Int Immunopharmacol. 2025 Aug 28;161:115028. doi: 10.1016/j.intimp.2025.115028. Epub 2025 Jun 9.
2
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD004197. doi: 10.1002/14651858.CD004197.pub5.
3
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4.
4
Unveiling the molecular mechanisms of human platelet lysate in enhancing endometrial receptivity.揭示人血小板裂解物增强子宫内膜容受性的分子机制。
Hum Reprod. 2025 Jul 15. doi: 10.1093/humrep/deaf118.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD003543. doi: 10.1002/14651858.CD003543.pub3.
7
Delayed antibiotics for symptoms and complications of respiratory infections.针对呼吸道感染症状及并发症延迟使用抗生素。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD004417. doi: 10.1002/14651858.CD004417.pub2.
8
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.针对囊性纤维化患者中耐甲氧西林金黄色葡萄球菌(MRSA)的清除干预措施。
Cochrane Database Syst Rev. 2022 Dec 13;12(12):CD009650. doi: 10.1002/14651858.CD009650.pub5.
9
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD009530. doi: 10.1002/14651858.CD009530.pub5.
10
Interventions for recurrent corneal erosions.复发性角膜糜烂的干预措施。
Cochrane Database Syst Rev. 2018 Jul 9;7(7):CD001861. doi: 10.1002/14651858.CD001861.pub4.